25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Epigral Limited
Buy, Hold or Sell?

Let's analyze Epigral Limited together

I guess you are interested in Epigral Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Epigral Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Epigral Limited

I send you an email if I find something interesting about Epigral Limited.

1. Quick Overview

1.1. Quick analysis of Epigral Limited (30 sec.)










1.2. What can you expect buying and holding a share of Epigral Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.28
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
INR257.30
Expected worth in 1 year
INR1,286.46
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
INR1,052.48
Return On Investment
49.5%

For what price can you sell your share?

Current Price per Share
INR2,126.30
Expected price per share
INR1,817 - INR2,368
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Epigral Limited (5 min.)




Live pricePrice per Share (EOD)
INR2,126.30
Intrinsic Value Per Share
INR604.68 - INR727.36
Total Value Per Share
INR861.99 - INR984.66

2.2. Growth of Epigral Limited (5 min.)




Is Epigral Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$126.1m$59.1k$126m100.0%

How much money is Epigral Limited making?

Current yearPrevious yearGrowGrow %
Making money472.00$210.3k-$209.8k-44,469.2%
Net Profit Margin0.0%71.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Epigral Limited (5 min.)




2.4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Epigral Limited?

Welcome investor! Epigral Limited's management wants to use your money to grow the business. In return you get a share of Epigral Limited.

First you should know what it really means to hold a share of Epigral Limited. And how you can make/lose money.

Speculation

The Price per Share of Epigral Limited is INR2,126. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Epigral Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Epigral Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR257.30. Based on the TTM, the Book Value Change Per Share is INR257.29 per quarter. Based on the YOY, the Book Value Change Per Share is INR0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR5.83 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Epigral Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share3.040.1%3.040.1%0.000.0%0.760.0%0.610.0%
Usd Dividend Per Share0.070.0%0.070.0%0.000.0%0.020.0%0.010.0%
Usd Total Gains Per Share3.100.1%3.100.1%0.000.0%0.770.0%0.620.0%
Usd Price Per Share14.70-14.70-8.91-5.90-4.72-
Price to Earnings Ratio1,294,080.98-1,294,080.98-15,260.33-327,335.33-261,868.26-
Price-to-Total Gains Ratio4.73-4.73-15,260.34-7,632.54-7,632.54-
Price to Book Ratio4.84-4.84-54,298.68-13,575.88-10,860.70-
Price-to-Total Gains Ratio4.73-4.73-15,260.34-7,632.54-7,632.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share25.09034
Number of shares39
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.02
Usd Book Value Change Per Share3.040.76
Usd Total Gains Per Share3.100.77
Gains per Quarter (39 shares)121.0930.22
Gains per Year (39 shares)484.35120.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1114744743118111
2219479586236232
332142114429354353
4431894192612472474
5542368241014590595
6642842289417708716
7753315337820826837
8863789386223944958
997426343462610621079
10107473648302911801200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.01.00.080.0%4.01.00.080.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.01.00.075.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%2.00.02.050.0%2.00.03.040.0%2.00.03.040.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.01.00.075.0%4.01.00.080.0%4.01.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Epigral Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--257.289257.2890%0.049+519874%64.083+301%51.461+400%
Book Value Per Share--257.303257.3030%0.014+1850149%64.290+300%51.626+398%
Current Ratio--0.6480.6480%9.075-93%5.736-89%4.950-87%
Debt To Asset Ratio--0.5600.5600%0.095+490%0.920-39%0.871-36%
Debt To Equity Ratio--1.2751.2750%0.105+1116%0.345+270%0.694+84%
Dividend Per Share--5.8305.8300%-+100%1.575+270%1.260+363%
Enterprise Value--38131888160.00038131888160.0000%272056216380.000-86%155094052270.000-75%155094052270.000-75%
Eps--0.0010.0010%0.049-98%0.259-100%0.206-100%
Ev To Ebitda Ratio--5.4725.4720%54.277-90%29.874-82%29.874-82%
Ev To Sales Ratio--277.359277.3590%10828.789-97%5553.074-95%5553.074-95%
Free Cash Flow Per Share--50.47150.4710%-4.787+109%10.226+394%8.093+524%
Free Cash Flow To Equity Per Share--54.08154.0810%-5.018+109%11.071+388%8.860+510%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--727.355--------
Intrinsic Value_10Y_min--604.684--------
Intrinsic Value_1Y_max--27.957--------
Intrinsic Value_1Y_min--27.165--------
Intrinsic Value_3Y_max--118.240--------
Intrinsic Value_3Y_min--111.057--------
Intrinsic Value_5Y_max--249.805--------
Intrinsic Value_5Y_min--226.567--------
Market Cap88348190260.000+41%51763239160.00051763239160.0000%272056489200.000-81%80954932090.000-36%64763945672.000-20%
Net Profit Margin--0.0000.0000%0.710-100%7.018-100%5.614-100%
Operating Margin----0%-0%-0%-0%
Operating Ratio--117.945117.9450%449.143-74%247.918-52%198.509-41%
Pb Ratio8.264+41%4.8424.8420%54298.682-100%13575.881-100%10860.705-100%
Pe Ratio2208704.757+41%1294080.9791294080.9790%15260.333+8380%327335.328+295%261868.262+394%
Price Per Share2126.300+41%1245.8001245.8000%755.100+65%500.225+149%400.180+211%
Price To Free Cash Flow Ratio42.129+41%24.68424.6840%-157.730+739%-33.262+235%-26.609+208%
Price To Total Gains Ratio8.081+41%4.7354.7350%15260.342-100%7632.538-100%7632.538-100%
Quick Ratio--0.2860.2860%4914.662-100%1230.532-100%984.751-100%
Return On Assets--0.0000.0000%3.220-100%2.493-100%1.994-100%
Return On Equity--0.0000.0000%3.558-100%0.890-100%0.710-100%
Total Gains Per Share--263.119263.1190%0.049+531656%65.658+301%52.720+399%
Usd Book Value--126153823.600126153823.6000%59122.366+213277%31386166.428+302%25933102.868+386%
Usd Book Value Change Per Share--3.0363.0360%0.001+519874%0.756+301%0.607+400%
Usd Book Value Per Share--3.0363.0360%0.000+1850149%0.759+300%0.609+398%
Usd Dividend Per Share--0.0690.0690%-+100%0.019+270%0.015+363%
Usd Enterprise Value--449956280.288449956280.2880%3210263353.284-86%1830109816.786-75%1830109816.786-75%
Usd Eps--0.0000.0000%0.001-98%0.003-100%0.002-100%
Usd Free Cash Flow--24745461.40024745461.4000%-20352935.000+182%-3980600.200+116%-3558431.222+114%
Usd Free Cash Flow Per Share--0.5960.5960%-0.056+109%0.121+394%0.095+524%
Usd Free Cash Flow To Equity Per Share--0.6380.6380%-0.059+109%0.131+388%0.105+510%
Usd Market Cap1042508645.068+41%610806222.088610806222.0880%3210266572.560-81%955268198.662-36%764214558.930-20%
Usd Price Per Share25.090+41%14.70014.7000%8.910+65%5.903+149%4.722+211%
Usd Profit--472.000472.0000%210366.742-100%1101650.301-100%876187.170-100%
Usd Revenue--1622287.6001622287.6000%296456.356+447%1001378.002+62%4280465.387-62%
Usd Total Gains Per Share--3.1053.1050%0.001+531656%0.775+301%0.622+399%
 EOD+4 -4MRQTTM+0 -0YOY+18 -205Y+19 -1910Y+18 -20

3.3 Fundamental Score

Let's check the fundamental score of Epigral Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152,208,704.757
Price to Book Ratio (EOD)Between0-18.264
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.286
Current Ratio (MRQ)Greater than10.648
Debt to Asset Ratio (MRQ)Less than10.560
Debt to Equity Ratio (MRQ)Less than11.275
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Epigral Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.742
Ma 20Greater thanMa 502,048.585
Ma 50Greater thanMa 1002,103.274
Ma 100Greater thanMa 2001,999.323
OpenGreater thanClose2,194.950
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Epigral Limited

  • Chemicals
  • 936

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-12-05 03:13:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Epigral Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • A Net Profit Margin of 0.0% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Epigral Limited:

  • The MRQ is 0.0%. The company is not making a profit/loss.
  • The TTM is 0.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY71.0%-70.9%
TTM0.0%5Y701.8%-701.8%
5Y701.8%10Y561.4%+140.4%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%2.9%-2.9%
TTM0.0%2.2%-2.2%
YOY71.0%3.8%+67.2%
5Y701.8%4.9%+696.9%
10Y561.4%5.2%+556.2%
4.3.1.2. Return on Assets

Shows how efficient Epigral Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • 0.0% Return on Assets means that Epigral Limited generated ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Epigral Limited:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY322.0%-322.0%
TTM0.0%5Y249.3%-249.3%
5Y249.3%10Y199.4%+49.9%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%0.6%-0.6%
TTM0.0%0.5%-0.5%
YOY322.0%0.9%+321.1%
5Y249.3%1.0%+248.3%
10Y199.4%1.2%+198.2%
4.3.1.3. Return on Equity

Shows how efficient Epigral Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • 0.0% Return on Equity means Epigral Limited generated ₹0.00 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Epigral Limited:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY355.8%-355.8%
TTM0.0%5Y89.0%-89.0%
5Y89.0%10Y71.0%+17.9%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%1.2%-1.2%
TTM0.0%1.1%-1.1%
YOY355.8%1.5%+354.3%
5Y89.0%1.9%+87.1%
10Y71.0%2.2%+68.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Epigral Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Epigral Limited is operating .

  • Measures how much profit Epigral Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Epigral Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%-4.7%
TTM-3.4%-3.4%
YOY-4.1%-4.1%
5Y-6.0%-6.0%
10Y-5.9%-5.9%
4.3.2.2. Operating Ratio

Measures how efficient Epigral Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 117.94 means that the operating costs are ₹117.94 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Epigral Limited:

  • The MRQ is 117.945. The company is inefficient in keeping operating costs low. -1
  • The TTM is 117.945. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ117.945TTM117.9450.000
TTM117.945YOY449.143-331.198
TTM117.9455Y247.918-129.973
5Y247.91810Y198.509+49.409
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ117.9451.710+116.235
TTM117.9451.667+116.278
YOY449.1431.619+447.524
5Y247.9181.571+246.347
10Y198.5091.298+197.211
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Epigral Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Epigral Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 0.65 means the company has ₹0.65 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Epigral Limited:

  • The MRQ is 0.648. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.648. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.648TTM0.6480.000
TTM0.648YOY9.075-8.428
TTM0.6485Y5.736-5.088
5Y5.73610Y4.950+0.786
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6481.480-0.832
TTM0.6481.563-0.915
YOY9.0751.662+7.413
5Y5.7361.778+3.958
10Y4.9501.617+3.333
4.4.3.2. Quick Ratio

Measures if Epigral Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • A Quick Ratio of 0.29 means the company can pay off ₹0.29 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Epigral Limited:

  • The MRQ is 0.286. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.286. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.2860.000
TTM0.286YOY4,914.662-4,914.376
TTM0.2865Y1,230.532-1,230.246
5Y1,230.53210Y984.751+245.781
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.547-0.261
TTM0.2860.616-0.330
YOY4,914.6620.810+4,913.852
5Y1,230.5320.846+1,229.686
10Y984.7510.858+983.893
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Epigral Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Epigral Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Epigral Limited to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.56 means that Epigral Limited assets are financed with 56.0% credit (debt) and the remaining percentage (100% - 56.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Epigral Limited:

  • The MRQ is 0.560. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.560. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.5600.000
TTM0.560YOY0.095+0.466
TTM0.5605Y0.920-0.359
5Y0.92010Y0.871+0.049
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5600.441+0.119
TTM0.5600.437+0.123
YOY0.0950.416-0.321
5Y0.9200.413+0.507
10Y0.8710.410+0.461
4.5.4.2. Debt to Equity Ratio

Measures if Epigral Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Epigral Limited to the Chemicals industry mean.
  • A Debt to Equity ratio of 127.5% means that company has ₹1.28 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Epigral Limited:

  • The MRQ is 1.275. The company is able to pay all its debts with equity. +1
  • The TTM is 1.275. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.275TTM1.2750.000
TTM1.275YOY0.105+1.170
TTM1.2755Y0.345+0.930
5Y0.34510Y0.694-0.349
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2750.840+0.435
TTM1.2750.835+0.440
YOY0.1050.748-0.643
5Y0.3450.765-0.420
10Y0.6940.829-0.135
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Epigral Limited generates.

  • Above 15 is considered overpriced but always compare Epigral Limited to the Chemicals industry mean.
  • A PE ratio of 1,294,080.98 means the investor is paying ₹1,294,080.98 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Epigral Limited:

  • The EOD is 2,208,704.757. Based on the earnings, the company is expensive. -2
  • The MRQ is 1,294,080.979. Based on the earnings, the company is expensive. -2
  • The TTM is 1,294,080.979. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2,208,704.757MRQ1,294,080.979+914,623.778
MRQ1,294,080.979TTM1,294,080.9790.000
TTM1,294,080.979YOY15,260.333+1,278,820.646
TTM1,294,080.9795Y327,335.328+966,745.651
5Y327,335.32810Y261,868.262+65,467.066
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD2,208,704.75713.999+2,208,690.758
MRQ1,294,080.97914.132+1,294,066.847
TTM1,294,080.97913.006+1,294,067.973
YOY15,260.33313.255+15,247.078
5Y327,335.32814.943+327,320.385
10Y261,868.26222.593+261,845.669
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Epigral Limited:

  • The EOD is 42.129. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 24.684. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 24.684. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD42.129MRQ24.684+17.446
MRQ24.684TTM24.6840.000
TTM24.684YOY-157.730+182.413
TTM24.6845Y-33.262+57.945
5Y-33.26210Y-26.609-6.652
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD42.1292.351+39.778
MRQ24.6842.791+21.893
TTM24.6840.035+24.649
YOY-157.730-0.197-157.533
5Y-33.2620.189-33.451
10Y-26.6091.332-27.941
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Epigral Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 4.84 means the investor is paying ₹4.84 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Epigral Limited:

  • The EOD is 8.264. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.842. Based on the equity, the company is fair priced.
  • The TTM is 4.842. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD8.264MRQ4.842+3.422
MRQ4.842TTM4.8420.000
TTM4.842YOY54,298.682-54,293.841
TTM4.8425Y13,575.881-13,571.039
5Y13,575.88110Y10,860.705+2,715.176
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD8.2641.418+6.846
MRQ4.8421.307+3.535
TTM4.8421.371+3.471
YOY54,298.6821.586+54,297.096
5Y13,575.8811.696+13,574.185
10Y10,860.7052.241+10,858.464
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets24,322,353
Total Liabilities13,631,351
Total Stockholder Equity10,691,002
 As reported
Total Liabilities 13,631,351
Total Stockholder Equity+ 10,691,002
Total Assets = 24,322,353

Assets

Total Assets24,322,353
Total Current Assets4,194,993
Long-term Assets20,127,360
Total Current Assets
Cash And Cash Equivalents 142,400
Short-term Investments 191,143
Net Receivables 1,663,223
Inventory 2,118,282
Other Current Assets 78,498
Total Current Assets  (as reported)4,194,993
Total Current Assets  (calculated)4,193,546
+/- 1,447
Long-term Assets
Long-term Assets Other 162,348
Long-term Assets  (as reported)20,127,360
Long-term Assets  (calculated)162,348
+/- 19,965,012

Liabilities & Shareholders' Equity

Total Current Liabilities6,476,905
Long-term Liabilities7,154,446
Total Stockholder Equity10,691,002
Total Current Liabilities
Short Long Term Debt 3,315,034
Accounts payable 1,101,730
Other Current Liabilities 117,539
Total Current Liabilities  (as reported)6,476,905
Total Current Liabilities  (calculated)4,534,303
+/- 1,942,602
Long-term Liabilities
Long term Debt 5,446,404
Capital Lease Obligations Min Short Term Debt26,184
Long-term Liabilities  (as reported)7,154,446
Long-term Liabilities  (calculated)5,472,588
+/- 1,681,858
Total Stockholder Equity
Total Stockholder Equity (as reported)10,691,002
Total Stockholder Equity (calculated)0
+/- 10,691,002
Other
Capital Stock415,502
Common Stock Shares Outstanding 41,550
Net Debt 8,619,038
Net Invested Capital 19,452,440
Net Working Capital -2,281,912



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,079,097
665,368
71,314
51,084
77,595
5,536
24,322,353
24,322,3535,53677,59551,08471,314665,3681,079,097
   > Total Current Assets 
588,566
23,928
13,163
31,057
57,969
4,768
4,194,993
4,194,9934,76857,96931,05713,16323,928588,566
       Cash And Cash Equivalents 
1,513
2,479
0
1,195
2,679
250,854
142,400
142,400250,8542,6791,19502,4791,513
       Short-term Investments 
0
0
0
0
0
18,769
191,143
191,14318,76900000
       Net Receivables 
518,599
0
0
4,801
42,822
2,563,240
1,663,223
1,663,2232,563,24042,8224,80100518,599
       Inventory 
39,904
0
0
14,623
5,783
1,541,389
2,118,282
2,118,2821,541,3895,78314,6230039,904
       Other Current Assets 
16,592
20,141
7,978
10,438
4,965
4,516
78,498
78,4984,5164,96510,4387,97820,14116,592
   > Long-term Assets 
0
0
0
11,413,792
12,674,103
16,767,220
20,127,360
20,127,36016,767,22012,674,10311,413,792000
       Property Plant Equipment 
455,605
638,849
56,637
18,632
18,626
7
0
0718,62618,63256,637638,849455,605
       Goodwill 
31,591
0
0
0
0
0
0
00000031,591
       Intangible Assets 
0
0
0
0
316,591
284,267
0
0284,267316,5910000
       Long-term Assets Other 
0
0
0
0
0
100
162,348
162,34810000000
> Total Liabilities 
729,872
782,697
439,705
94,900
90,413
525
13,631,351
13,631,35152590,41394,900439,705782,697729,872
   > Total Current Liabilities 
326,078
345,916
370,255
5,752
7,413
525
6,476,905
6,476,9055257,4135,752370,255345,916326,078
       Short-term Debt 
299,980
303,649
310,094
0
0
0
0
0000310,094303,649299,980
       Short Long Term Debt 
0
0
0
1,079,206
1,978,440
2,212,180
3,315,034
3,315,0342,212,1801,978,4401,079,206000
       Accounts payable 
0
0
0
467,924
730,493
881,050
1,101,730
1,101,730881,050730,493467,924000
       Other Current Liabilities 
0
0
0
0
0
260,633
117,539
117,539260,63300000
   > Long-term Liabilities 
0
0
0
4,251,718
3,759,612
8,654,067
7,154,446
7,154,4468,654,0673,759,6124,251,718000
       Long term Debt Total 
356,940
436,782
69,449
89,149
75,000
0
0
0075,00089,14969,449436,782356,940
       Capital Lease Obligations Min Short Term Debt
-299,980
-303,649
-310,094
43,945
37,555
37,622
26,184
26,18437,62237,55543,945-310,094-303,649-299,980
> Total Stockholder Equity
349,224
-117,330
-368,390
-43,817
-12,817
5,010
10,691,002
10,691,0025,010-12,817-43,817-368,390-117,330349,224
   Common Stock
360,292
360,292
360,292
360,292
360,292
360,292
0
0360,292360,292360,292360,292360,292360,292
   Retained Earnings 0-355,282-373,109-404,109-728,682-477,622-11,068
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue137,482
Cost of Revenue-131,236
Gross Profit6,2466,246
 
Operating Income (+$)
Gross Profit6,246
Operating Expense-16,084,056
Operating Income-485-16,077,810
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,309
Selling And Marketing Expenses0
Operating Expense16,084,0562,309
 
Net Interest Income (+$)
Interest Income7
Interest Expense-655,022
Other Finance Cost-7
Net Interest Income-655,022
 
Pretax Income (+$)
Operating Income-485
Net Interest Income-655,022
Other Non-Operating Income Expenses0
Income Before Tax (EBT)40-485
EBIT - interestExpense = -655,022
40
655,062
Interest Expense655,022
Earnings Before Interest and Taxes (EBIT)0655,062
Earnings Before Interest and Taxes (EBITDA)6,969,144
 
After tax Income (+$)
Income Before Tax40
Tax Provision-0
Net Income From Continuing Ops3,532,90640
Net Income40
Net Income Applicable To Common Shares40
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0655,022
 

Technical Analysis of Epigral Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Epigral Limited. The general trend of Epigral Limited is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Epigral Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Epigral Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2,233 < 2,359 < 2,368.

The bearish price targets are: 1,890 > 1,881 > 1,817.

Tweet this
Epigral Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Epigral Limited. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Epigral Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Epigral Limited. The current macd is 20.57.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Epigral Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Epigral Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Epigral Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Epigral Limited Daily Moving Average Convergence/Divergence (MACD) ChartEpigral Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Epigral Limited. The current adx is 14.75.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Epigral Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Epigral Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Epigral Limited. The current sar is 2,002.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Epigral Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Epigral Limited. The current rsi is 54.74. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Epigral Limited Daily Relative Strength Index (RSI) ChartEpigral Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Epigral Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Epigral Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Epigral Limited Daily Stochastic Oscillator ChartEpigral Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Epigral Limited. The current cci is 95.57.

Epigral Limited Daily Commodity Channel Index (CCI) ChartEpigral Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Epigral Limited. The current cmo is 14.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Epigral Limited Daily Chande Momentum Oscillator (CMO) ChartEpigral Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Epigral Limited. The current willr is -27.29591837.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Epigral Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Epigral Limited Daily Williams %R ChartEpigral Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Epigral Limited.

Epigral Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Epigral Limited. The current atr is 87.49.

Epigral Limited Daily Average True Range (ATR) ChartEpigral Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Epigral Limited. The current obv is 364,094.

Epigral Limited Daily On-Balance Volume (OBV) ChartEpigral Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Epigral Limited. The current mfi is 85.50.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Epigral Limited Daily Money Flow Index (MFI) ChartEpigral Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Epigral Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Epigral Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Epigral Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.742
Ma 20Greater thanMa 502,048.585
Ma 50Greater thanMa 1002,103.274
Ma 100Greater thanMa 2001,999.323
OpenGreater thanClose2,194.950
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Epigral Limited with someone you think should read this too:
  • Are you bullish or bearish on Epigral Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Epigral Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Epigral Limited

I send you an email if I find something interesting about Epigral Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Epigral Limited.

Receive notifications about Epigral Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.